- Report
- October 2024
- 199 Pages
Global
From €3348EUR$3,545USD£2,848GBP
€3720EUR$3,939USD£3,164GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Besifloxacin is an antibiotic used to treat bacterial infections in humans. It belongs to the fluoroquinolone class of antibiotics, which are used to treat a wide range of bacterial infections. Besifloxacin is used to treat bacterial conjunctivitis, a common eye infection, as well as other bacterial infections of the eye. It is also used to treat bacterial infections of the skin, such as cellulitis, impetigo, and folliculitis. Besifloxacin is available in both ophthalmic and topical formulations.
Besifloxacin is a relatively new antibiotic, and its market is still in its early stages. It is used mainly in the treatment of bacterial eye infections, and is gaining popularity due to its effectiveness and safety profile. Besifloxacin is also being studied for its potential use in the treatment of other bacterial infections.
Some companies in the Besifloxacin market include Bausch & Lomb, Allergan, Merck, and Pfizer. Show Less Read more